ADENA T. FRIEDMAN

President and Chief Executive Officer
pharmaceutic
NASDAQ
Cambodia

Business Expert Pharmaceutical Sciences
Biography

Ms. Friedman assumed the role of President and Chief Executive Officer of Nasdaq on January 1, 2017 and is a member of the Board of Directors. Ms. Friedman brings more than 20 years of industry leadership and expertise and is credited with significant contributions that shaped Nasdaq’s strategic transformation to a leading global exchange and technology solutions company with operations on six continents.

Research Intrest

sciencw

Global Scientific Words in Pharmaceutical Sciences